Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR1405-01 for post-abdominal surgery pain
ChiCTR2500112614Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of HR1405-01 in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Area under curve of pain intensity-time during 0–24 h at rest. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
HR1405-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500112614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112614.